British journal of cancer

Br J Cancer · ISSN (print) 0007-0920 · 130 papers in corpus
observational 2017
doi:10.1038/bjc.2017.127 ·PMID:28494470

BACKGROUND: Pre-existing non-cancer conditions may complicate and delay colorectal cancer diagnosis. METHOD: Incident cases (aged ⩾40 years, 2007-2009) with colorectal cancer were identified in the Clinical Practice Research Datalink, UK. …

observational 2017
doi:10.1038/bjc.2017.35 ·PMID:28208158

BACKGROUND: Various epidemiologic factors have been shown to influence the risk of ovarian cancer development. Given the high fatality associated with this disease, it is of interest to evaluate the association of prediagnostic hormonal, re…

2017
doi:10.1038/bjc.2017.194 ·PMID:28664917

BackgroundEndometrial cancer is the most common gynaecological cancer and its incidence is predicted to escalate by 50-100% in 2025 with a parallel increase in associated mortality. Variations in the collection, processing and storage of bi…

other 2017
doi:10.1038/bjc.2017.161 ·PMID:28609433

BACKGROUND: Work-related cancer is an important public health issue with a large financial impact on society. The key European legislative instrument is the Carcinogens and Mutagens Directive (2004/37/EC). In preparation for updating the Di…

observational 2017
doi:10.1038/bjc.2017.246 ·PMID:28772285

BACKGROUND: We used a food-based empirical dietary inflammatory pattern (EDIP) score to investigate whether diets with higher inflammatory potential are associated with increased ovarian cancer risk. METHODS: We followed 186 314 women in t…

observational 2016
doi:10.1038/bjc.2016.39 ·PMID:26908324

BACKGROUND: Existing literature examining analgesic medication use and epithelial ovarian cancer (EOC) risk has been inconsistent, with the majority of studies reporting an inverse association. Race-specific effects of this relationship hav…

observational 2016
doi:10.1038/bjc.2016.193 ·PMID:27336600

BACKGROUND: Lynch syndrome (LS) is associated with a significant lifetime risk of endometrial cancer (EC). There are limited data on factors modifying the EC risk in LS patients. METHODS: The study cohort included 136 LS mutation-positive …

rct 2016
doi:10.1038/bjc.2016.247 ·PMID:27537387

BACKGROUND: The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and l…

observational 2016
doi:10.1038/bjc.2016.316 ·PMID:27701384

BACKGROUND: Ovarian cancer survival is poor, particularly for platinum-resistant cases. The previous literature on pre-diagnostic reproductive factors and ovarian cancer survival has been mixed. Therefore, we evaluated pre-diagnostic reprod…

observational 2016
doi:10.1038/bjc.2016.80 ·PMID:27115569

BACKGROUND: Tubal ligation is known to be associated with a reduction in ovarian cancer risk. Associations with breast, endometrial and cervical cancers have been suggested. We investigated associations for 26 site-specific cancers in a lar…

observational 2015
doi:10.1038/bjc.2015.22 ·PMID:25742479

BACKGROUND: Ovarian cancer has a high case-fatality ratio, largely due to late diagnosis. Epidemiologic risk prediction models could help identify women at increased risk who may benefit from targeted prevention measures, such as screening …

other 2015
doi:10.1038/bjc.2015.24 ·PMID:25688738

BACKGROUND: Nulliparity is an endometrial cancer risk factor, but whether or not this association is due to infertility is unclear. Although there are many underlying infertility causes, few studies have assessed risk relations by specific …

observational 2015
doi:10.1038/bjc.2014.574 ·PMID:25393364

BACKGROUND: Limited data suggest that statin use reduces the risk for ovarian cancer. METHODS: Using Danish nationwide registries, we identified 4103 cases of epithelial ovarian cancer during 2000-2011 and age-matched them to 58,706 risk-s…

observational 2014
doi:10.1038/bjc.2014.16 ·PMID:24473401

BACKGROUND: Studies of fat intake and epithelial ovarian cancer (EOC) risk have reported inconsistent findings, hence we hypothesised that associations may vary by histologic subtype. METHODS: We evaluated fat intake in a New England case-…

2014
other 2014
doi:10.1038/bjc.2014.340 ·PMID:24967874

BACKGROUND: There are limited data and guidance from the UK on borderline nuclear change in endocervical cells (BNCs). The objective of this study is to determine the clinical outcome of women with BNCs, to determine the accuracy of colposc…

meta-analysis 2014
doi:10.1038/bjc.2014.29 ·PMID:24518590

BACKGROUND: The risk and prognosis of ovarian cancer have not been well established in women with endometriosis. Thus, we investigated the impact of endometriosis on the risk and prognosis for ovarian cancer, and evaluated clinicopathologic…

meta-analysis 2014
doi:10.1038/bjc.2014.333 ·PMID:24937676

BACKGROUND: To compare different ultrasound-based international ovarian tumour analysis (IOTA) strategies and risk of malignancy index (RMI) for ovarian cancer diagnosis using a meta-analysis approach of centre-specific data from IOTA3. ME…

observational 2013
doi:10.1038/bjc.2013.344 ·PMID:23820255

BACKGROUND: Recent studies have suggested that several ovarian cancer risk factors differ by parity status, but these findings have not been confirmed. We evaluated whether known risk factors of ovarian cancer differ between nulliparous and…

nonrandomized-trial 2013
doi:10.1038/bjc.2013.375 ·PMID:23868012

BACKGROUND: Endovaginal MRI (evMRI) at 3.0-T with T2-weighted (T2-W) and ZOnal Oblique Multislice (ZOOM)-diffusion-weighted imaging (DWI) potentially improves the detection of stage Ia/Ib1 cervical cancer. We aimed to determine its sensitiv…

review 2013
doi:10.1038/bjc.2013.126 ·PMID:23558892

Ovarian clear cell carcinomas (OCCCs) account for about 5-13% of all epithelial ovarian carcinomas in Western populations. It is characterised by resistance to conventional platinum-based chemotherapy, and new therapeutic strategies are urg…

2013
doi:10.1038/bjc.2013.51 ·PMID:23403818

BackgroundNY-ESO-1 antibodies are specifically observed in patients with NY-ESO-1-expressing tumours. We analysed whether the NY-ESO-1 humoral immune response is a useful tumour marker of gastric cancer.MethodsSera from 363 gastric cancer p…

lab-animal 2012
doi:10.1038/bjc.2012.26 ·PMID:22353808

BACKGROUND: Epithelial cells of endometriotic tissues are difficult to propagate in vitro as experimental material is scarce owing to their limited life span. However, there is an increasing concern regarding their malignant transformation …

other 2012
doi:10.1038/bjc.2012.246 ·PMID:22653145

BACKGROUND: This study examined the clinical significance of NAC1 and the expression level of its potential downstream target fatty acid synthase (FASN) in ovarian clear cell carcinomas (OCCCs), and evaluated the NAC1/FASN pathway as a pote…

lab-animal 2012
doi:10.1038/bjc.2012.67 ·PMID:22415234

BACKGROUND: Genomic stability is one of the crucial prognostic factors for patients with endometrioid endometrial cancer (EEC). The impact of genomic stability on the tumour tissue proteome of EEC is not yet well established. METHODS: Tiss…